This page outlines the application process for researchers to access the Australian Autism Biobank. An overview of the process is illustrated below.
What data is available
The following tables give a brief overview of the samples availability and categories. More detailed information can be provided during the application process.
Category | Dataset | Short name | Mother* | Father* | Proband | Sibling | Control |
---|---|---|---|---|---|---|---|
Diagnostic Assessments | Autism Diagnostic Observation Schedule – 2 (Mod 1 -4) | ADOS | 1125 | 1 | |||
The Developmental, Diagnostic, and Dimensional Interview | 3DI | 785 | |||||
Cognitive Testing | Mullen Scales of Early Learning (2 – 5 yrs 11 months) | MSEL | 419 | 84 | 85 | ||
Wechsler Intelligence Scale for Children – 4th ed (6-17 years) | WISC | 436 | 151 | 61 | |||
Wechsler Abbreviated Scale of Intelligence – 2nd Edition | WASI-I | 726 | 457 | ||||
Questionnaires | Vineland Adaptive Behaviour Scales 2nd Edition | VABS | 878 | ||||
Family History Questionnaire | FHQ | 1025 | 235 | 129 | |||
Child Development Questionnaire | CDQ | ||||||
Children’s Communication Checklist | CCC | 772 | |||||
Communication Checklist – Adult | CCA | 650 | 608 | 28 mothers, 26 fathers | |||
Broad Autism Phenotype | BAP | 756 | 738 | 115 mothers, 115 fathers | |||
Social Responsiveness Scale | SRS | 50 | 175 | 123 | |||
Short Sensory Profile – 2 | SSP | 713 | |||||
Early Concerns | EAC | 423 | |||||
Oral Health Survey | OHS | 153 | |||||
Physical / dietary characteristics | Food Frequency Questionnaire (Australian Eating Survey) | FFQ | 180 | 75 | 84 | ||
Tanner scales | TS | 271 | 90 | 27 | |||
Clinical Proforma | CP | 1103 | 252 | 149 |
Category | Dataset | Short name | Source | Mother* | Father* | Proband | Sibling | Control |
---|---|---|---|---|---|---|---|---|
DNA related | Whole Genome Sequencing | WGS | 437 | 437 | 530 | 135 | ||
Genomic Wide Association Study & Single Nucleotide Polymorphism | GWAS/SNIPS | 752 | 504 | 887 | 218 | 116 | ||
Metagenomic | Stool | 100 | 50 | 49 | ||||
Methylation | Buffy coat | 255 | 125 | 68 | ||||
Polygenic scores | PGS | 887 | 217 | 117 |
Dataset | Source | Mother* | Father* | Proband | Sibling | Control |
---|---|---|---|---|---|---|
Cortisol | Hair | 356 | 162 | 131 | ||
Melatonin | Urine | 219 |
Category | Samples | Mother* | Father* | Proband | Sibling | Control |
---|---|---|---|---|---|---|
Blood | Plasma | 558 | 374 | 798 | 217 | 117 |
Serum | 586 | 394 | 698 | 218 | 78 | |
Red Blood cells (RBC) | 586 | 394 | 677 | 215 | 116 | |
Whole blood | 584 | 391 | 659 | 213 | 115 | |
Nucleic Acids | DNA | 584 | 529 | 659 | 136 | 0 |
RNA (Paxgene) | 131 | 89 | 150 | 55 | 9 | |
Other | Urine | 316 | 140 | 125 | ||
Stool | 215 | 95 | 78 | |||
Saliva | 4 | 2 | 18 | 10 | 6 |
Guiding Principles of Access
Access to the Australian Autism Biobank’s resources is underpinned by the following statements:
- The research provides practical and tangible outputs that benefit the community
- The data is used to build a baseline for the development of tools, new and enhanced evidence-based practice that support autistic people with quality of life and opportunities
- The resources used help to improve the understanding of the health and wellbeing of autistic individuals and develop new ways of making a meaningful impact in these areas.
Before you start the application process
If you are considering applying for access to the Biobank, we suggest familiarising yourself with the establishment of the Biobank, the research already undertaken, and the policy that determines whether access is granted.
- To learn more about the establishment of the Australian Autism Biobank, read Study protocol for the Australian Autism Biobank: an international resource to advance autism discovery research
- To find out what research has been undertaken, view our Publications and outputs page
- To find out the principles behind granting access, read the Biobank and Databank data and access sharing policy
Who can access data and how can the data be used
Oversight of the applications to use Australian Autism Biobank data is by the Autism CRC Access Committee. This committee consists of at least six people appointed by Autism CRC, including at least one member of the autistic or broader autism community.
The Committee meets bi-monthly, on the second Tuesday of February, April, June, August, October and December of each year.
The Autism CRC Access Committee will co-opt scientific advisers with expertise related to the specific project under evaluation where required. This committee will assess each application with respect to its:
- scientific merit, feasibility and priority of use of the material requested, and
- the impact on the Australian Autism Biobank in light of overall balance of resources and demand on specimens and data.
Anyone may apply to access Australian Autism Biobank data through the Autism CRC Access Committee. All applications must be considered and approved by the Access Committee before data or material can be shared.
Access to data will only ever be granted by this committee when researchers have approval from an appropriate Human Research Ethics Committee and where the Autism CRC Access Committee can identify a clear potential benefit of the proposed research to the autistic and autism communities.
Data access is subject to the Biobank and Databank access and data sharing policy. Projects must be approved by the Autism CRC Access Committee in addition to having institutional ethical clearance. Projects will be considered on their scientific merits and benefit to the community.
All past Participants, Members and Affiliates of the Autism CRC must also apply through Autism CRC Access Committee approval process.
Costs involved in application and access
There are costs associated with accessing materials and data from the Biobank. These charges contribute to the ongoing maintenance and upkeep of the Australian Autism Biobank asset. The costs in actively managing this asset include:
- Storage and upkeep of data and samples
- Receiving, considering, supporting and tracking applications
- Curating data analysis from approved projects
- Incorporating new and updated datasets, as appropriate, in the current dataset
- Maintaining a register of participants for recontact for Australian Autism Biobank follow up or future studies.
All these measures mean that the Australian Autism Biobank will continue to grow and provide an evolving and sustainable dataset for years to come. By continually investing in the upkeep and curation of the dataset, the original data and the new additions are always ready to use. Data access is on a cost-recovery basis, and also requires an appropriate Materials Transfer Agreement for commercial or non-commercial research.
These costs are outlined in the Australian Autism Biobank: Fee schedule.
Download Australian Autism Biobank: Fee schedule
Expression of Interest
If you have reviewed the information on this page and the linked resources and documents, you can start the process by submitting an Expression of Interest.